Mohammed Khanji, Ghoufran Kawas, Mohammad Haroun, Mouhammad Abu Rasheed, Amir Alhaj Sakur
email@example.com , firstname.lastname@example.org , email@example.com , firstname.lastname@example.org , Profsakur6@alepuniv.edu.sy
Mohammed Khanji1, Ghoufran Kawas1, Mohammad Haroun1, Mouhammad Abu Rasheed2, Amir Alhaj Sakur2
1Pharmaceutical Chemistry and Quality Control Dept., Faculty of Pharmacy, Al Andalus University, Tartous, Syria.
2Department of Food and Analytical Chemistry, Faculty of Pharmacy, University of Aleppo, Syria.
Volume - 13,
Issue - 5,
Year - 2020
Simple densitometric thin layer chromatographic method has been applied in this study to proceed forced degradation test of albendazole by subjecting drug to acidic, alkaline, oxidative, thermal, and photolytic conditions, and determine the degradation percentages of albendazole in these conditions after 1, 2, 4, and 6 hrs. Two different mobile phases have been used in this study to separate degradation products. chloroform:diethyl ether:glacial acetic acid (75:12.5:12.5, v/v) as mobile phase 1, and dichloromethane:methanol (90:10, v/v) as mobile phase 2. Silica gel GF-254 TLC-plates were used, and densitometric Area under curve (AUC) and AUC percentages were measured. Densitometric measurements showed that albendazole is unstable in all stress conditions but in different percentages, with the least susceptibility have been reported with acid condition (just 6.13% of drug lost after 6 hrs. of incubation). Acidic medium caused reversible degradation with homogeneity in the structures of degradation products, Unlike Alkaline medium which showed heterogeneity in structures detected through the change in the number and Rf-values of degradation spots against time. Both mobile phases were suitable for detecting albendazole degradation percentages under different conditions, as quantitative measurements were closely similar for the two phases, but mobile phase 1 was better to differentiate base-induced degradation products and mobile phase 2 was better for photolytic-induced degradation products.
Cite this article:
Mohammed Khanji, Ghoufran Kawas, Mohammad Haroun, Mouhammad Abu Rasheed, Amir Alhaj Sakur. Quantitative determination of albendazole forced degradation percentages by densitometric thin layer chromatographic method. Research J. Pharm. and Tech 2020; 13(5): 2207-2213. doi: 10.5958/0974-360X.2020.00396.0
1- Jaime ND, and William AR. Textbook of organic medicinal and pharmaceutical chemistry. 10th Edition. Philadelphia, PA: Lippincott Raven Publishers, 1988.
2- ICH Harmonized Tripartite Guideline. Impurities in New Drug Substances Q3A (R2), October 2006.
3- ICH Harmonized Tripartite Guideline. Impurities in New Drug Products Q3B (R2), June 2006.
4- Roy J. Pharmaceutical impurities-a mini-review. AAPS Pharm. Sci. Tech., 2002; 3(2):1-8.
5- Grekas N. organic impurities in chemical drug substances. Pharmaceutical Technology Europe, 2005; 17(10):24-32.
6- Rousseau G. international conference on harmonization impurity guidelines- the industry perspective. Drug Information Journal, 2000; 34:903-907.
7- British Pharmacopoeia. 7th edition. TSO Information and Publishing Solutions, 2013.
8- United States Pharmacopoeia and National Formulary USP 38 – NF 33, 2015.
9- ICH Topic Q1A (R2) Stability Testing of new Drug Substances and Products. August 2003.
10- Baertschi SW. The Role of Stress Testing in Pharmaceutical Product Development. The American Association of Pharmaceutical Scientists. Midwest Regional Meeting. Chicago, 1996.
11- Attia KAS, Mohamad AAH, Emara MS. Determination of Albendazole in the Presence of its Alkaline Degradation Product Using TLC-Densitometric and Chemometric Methods: A Comparative Study. Eurasian Journal of Analytical Chemistry, 2017; 12(4):365-383.
12- Ljubas D, Čizmić M, Vrbat K, Stipaničev D, Repec S, Ćurković L, Babić S. Albendazole Degradation Possibilities by UV-Based Advanced Oxidation Processes. International Journal of Photoenergy, 2018; 6181747.
13- Patel AK, Joshi HV, Patel JK. Development and validation of stability indicating RP-HPLC method for estimation of ivermectin and albendazole in pharmaceutical dosage form. Indian Journal of Drugs, 2015; 3(3), 57-70.
14- Ragno G, Risoli A, Ioele G, De Luca M. Photo- and Thermal-Stability Studies on Benzimidazole Anthelmintics by HPLC and GC-MS. Chem. Pharm. Bull., 2006; 54(6) 802-806.
15- Gomes AR, Nagaraju V. High-performance liquid chromatographic separation and determination of the process related impurities of mebendazole, fenbendazole and albendazole in bulk drugs. Journal of Pharmaceutical and Biomedical Analysis, 2001; 26: 919-927.